Autologous Stem Cell Transplant

6 drugs in development·3 companies·1 clinical trial

Drug Pipeline by Phase

Approved(1)

Drug	Company
Monjuvi	Xencor Inc (XNCR)

Phase 2(5)

Drug	Company
Bortezomib	Coeptis Therapeutics Holdings Inc. (COEP)
Daratumumab	Coeptis Therapeutics Holdings Inc. (COEP)
G-CSF	PTC THERAPEUTICS, INC. (PTCT)
GPC-100	PTC THERAPEUTICS, INC. (PTCT)
Propranolol	PTC THERAPEUTICS, INC. (PTCT)

BioSniper tracks 6 drugs in development for Autologous Stem Cell Transplant across 3 companies.

There are 1 clinical trial targeting Autologous Stem Cell Transplant tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.